SeaStar Medical Holding Corp's director and 10% owner, John Neuman, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The document, dated June 5, 2024, indicates that Neuman does not beneficially own any non-derivative or derivative securities of the company. The filing, which is a routine disclosure for individuals in Neuman's position, was completed on June 14, 2024. This formality is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting by directors, officers, and principal shareholders of public companies.

SeaStar Medical Holding Corp's director and 10% owner, John Neuman, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The document, dated June 5, 2024, indicates that Neuman does not beneficially own any non-derivative or derivative securities of the company. The filing, which is a routine disclosure for individuals in Neuman's position, was completed on June 14, 2024. This formality is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting by directors, officers, and principal shareholders of public companies.